CAS: 115404-57-4 - (5xi,13alpha,14beta,20S,23R,24S)-23-hydroxy-24,25-epoxylanost-7-en-3-one
Formel:C30H48O3
InChl:InChI=1S/C30H48O3/c1-18(17-22(31)25-27(4,5)33-25)19-11-15-30(8)21-9-10-23-26(2,3)24(32)13-14-28(23,6)20(21)12-16-29(19,30)7/h9,18-20,22-23,25,31H,10-17H2,1-8H3/t18-,19-,20-,22+,23-,25-,28+,29-,30+/m0/s1
InChI Key:InChIKey=GKQMMZUXYRXFOH-QBLSGNHRSA-N
SMILES:O=C1CCC2(C)C3C(=CCC2C1(C)C)C4(C)CCC(C(C)CC(O)C5OC5(C)C)C4(C)CC3
- Synonyme:
- (13α,14β,17α,20S,23R,24S)-24,25-Epoxy-23-hydroxylanost-7-en-3-one
- Lanost-7-en-3-one, 24,25-epoxy-23-hydroxy-, (13α,14β,17α,20S,23R,24S)-
- Niloticin
Marke | Produktdaten | Reinheit | Preisklasse | Voraussichtliche Lieferung |
---|---|---|---|---|
Lanost-7-en-3-one, 24,25-epoxy-23-hydroxy-, (13α,14β,17α,20S,23R,24S)- REF: IN-DA000FY8CAS: 115404-57-4 | 98.0% | Nachfragen | Mi 13 Nov 24 | |
Niloticin REF: TM-T20609CAS: 115404-57-4 | 98% | 508,00 € | Do 14 Nov 24 | |
Niloticin REF: BP-SBP00024CAS: 115404-57-4 | 95%~99% | Nachfragen | Mo 18 Nov 24 | |
Niloticin REF: 3D-QEA40457CAS: 115404-57-4 | Min. 95% | Nachfragen | Fr 27 Dez 24 |
Lanost-7-en-3-one, 24,25-epoxy-23-hydroxy-, (13α,14β,17α,20S,23R,24S)-
Ref: IN-DA000FY8
5mg | Nachfragen |
Niloticin
Ref: TM-T20609
5mg | 508,00 € |
Niloticin
Ref: BP-SBP00024
Unbestimmte Größe | Nachfragen |
Niloticin
Ref: 3D-QEA40457
5mg | Nachfragen | ||
10mg | Nachfragen | ||
25mg | Nachfragen | ||
50mg | Nachfragen |